Literature DB >> 18693172

Epidemiology of fatty liver in an islander population of China: a population-based case-control study.

Hui-Fen Dai1, Zhe Shen, Chao-Hui Yu, Xi-Cheng Zhang, You-Ming Li.   

Abstract

BACKGROUND: Because of difficulty in evaluating fatty liver disease in islander populations, we conducted a cross-sectional study to investigate the prevalence of fatty liver and its risk factors in an islander population of East China.
METHODS: Randomized multistage stratified cluster sampling from the islander population was used in a population-based case-control study. Then interview, physical examination, and ultrasonography were done.
RESULTS: Univariate logistic-regression analysis showed that male gender, smoking, daily alcohol intake > or =20 g, duration of drinking > or =5 years, total alcohol intake > or =36.5 kg, hypertension and obesity were closely related to fatty liver (all P<0.05). Multivariate stepwise logistic-regression analysis showed duration of drinking > or =5 years and obesity were closely related to fatty liver (both P<0.05), the odds-ratio (OR) (95% CI) was 1.954 (1.364-2.799) and 7.014 (4.919-10.002), respectively. The prevalence of fatty liver in this district was 40.0%. The prevalence of fatty liver in the non-obese and <5 years drinking group, the non-obese and > or =5 years drinking group, the obese and <5 years drinking group and the obese and > or =5 years drinking group were 15.43%, 26.73%, 56.78% and 71.52%, respectively. A dose-response relation between the duration of drinking and fatty liver was not apparent. After stratification by obesity, we found that the severity of fatty liver on ultrasonography was positively correlated with the duration of drinking level in the obese and non-obese groups, Pearson's correlation coefficients were 0.293 in the obese group and 0.178 in the non-obese group (both P<0.05).
CONCLUSIONS: The duration of drinking > or =5 years and obesity were two important risk factors for fatty liver in the islander population of East China. The prevalence of fatty liver in this population was high. An alcoholic threshold effect may be more important than a dose-response effect on the morbidity of fatty liver.

Entities:  

Mesh:

Year:  2008        PMID: 18693172

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  6 in total

1.  Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: Experience at a teaching hospital.

Authors:  Tao-Hsin Tung; Tsung-Hung Chang; Wei-Hsiu Chiu; Tzu-Han Lin; Hui-Chuan Shih; Ming-Huei Chang; Jorn-Hon Liu
Journal:  BMC Res Notes       Date:  2011-08-31

2.  The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia.

Authors:  Yong Tan; Xinru Liu; Ke Zhou; Xiaojuan He; Cheng Lu; Bing He; Xuyan Niu; Cheng Xiao; Gang Xu; Zhaoxiang Bian; Xianpeng Zu; Ge Zhang; Weidong Zhang; Aiping Lu
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

3.  An exploration of prevalence and associated factors of nonalcoholic Fatty liver disease in the taiwanese police service.

Authors:  Th Tung; Wh Chiu; Th Lin; Hc Shih; Ct Hsu
Journal:  Iran J Public Health       Date:  2011-12-31       Impact factor: 1.429

4.  The effect of pioglitazone and metformin on liver function tests, insulin resistance, and liver fat content in nonalcoholic Fatty liver disease: a randomized double blinded clinical trial.

Authors:  Mohsen Razavizade; Raika Jamali; Abbas Arj; Seyyed Mohammad Matini; Alireza Moraveji; Effat Taherkhani
Journal:  Hepat Mon       Date:  2013-05-21       Impact factor: 0.660

5.  Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan.

Authors:  Hsi-Che Shen; Zi-Hao Zhao; Yi-Chun Hu; Yu-Fen Chen; Tao-Hsin Tung
Journal:  Clin Interv Aging       Date:  2014-03-27       Impact factor: 4.458

6.  Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan.

Authors:  Jau-Yuan Chen; Chung-Te Hsu; Jorn-Hon Liu; Tao-Hsin Tung
Journal:  BMC Gastroenterol       Date:  2014-04-28       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.